Placement and Entitlement Offer to raise up to $7.1 million
Filed with ASX · · 5 pages · English
In the deck
Story so far
Earlier from OncoSil Medical
- 84 German hospitals can negotiate fee for Oncosil device
- OncoSil receives $1.1m R&D tax incentive
- First two commercial patient treatments in Greece
- OncoSil onboards first patient in PANCOSIL Clinical Trial
- Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer
Later from OncoSil Medical
- Prospectus - Entitlement Offer
- First Austria-based treatments utilising the OncoSil device
- First patient treated in the UK for the TRIPP-FXX study
- First patient treated with OncoSil device in Turkiye
- 1st Study in Man Increases Pancreatic Tumor Vascularity
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical